Publication | Open Access
CSPG4 as a Target of Antibody-Based Immunotherapy for Malignant Mesothelioma
83
Citations
33
References
2012
Year
These results establish the safety of CSPG4 mAb-based immunotherapy and suggest that CSPG4 mAb-based immunotherapy may represent a novel approach for the treatment of MM.
| Year | Citations | |
|---|---|---|
Page 1
Page 1